Emvose M 0.3 Tablet
By Emvose M
Rx
10 Tablet in a Strip

Composition
Metformin(500mg) + Voglibose(0.3mg)

Manufacturer - Medopharm
25,Puliyur 2'nd Main Road, Trustpuram, Kodambakkam, Chennai, Tamilnadu, India, Pincode 600024

Expires on or after
March, 2026
About Emvose M 0.3 Tablet
Emvose M 0.3 Tablet is classified as an anti-diabetic medication that is specifically designed to manage type 2 diabetes mellitus in adults. The purpose of this medication is to aid individuals in regulating their blood sugar levels effectively. It is recommended to consume Emvose M 0.3 Tablet alongside food daily at the same consistent time to maximize its benefits. Dosage adjustments may be necessary based on the medication's efficacy in controlling blood sugar levels.
Consistency in taking this medication is important, even if one feels well or their blood sugar levels are stable. Abruptly stopping this medication without medical guidance can lead to a rise in blood sugar levels, exposing individuals to various health risks such as kidney damage, vision impairment, nerve complications, and potential amputations. Emvose M 0.3 Tablet should be viewed as a component of an overarching treatment regimen that includes a nutritious diet, regular physical activity, and weight management as directed by a healthcare provider, emphasizing the significant role lifestyle choices play in effectively managing diabetes.
Potential side effects linked to Emvose M 0.3 Tablet consumption may include temporary symptoms like nausea, altered taste perception, reduced appetite, flatulence, abdominal discomfort, diarrhea, and skin rashes. Typically, these side effects diminish over time without intervention. If these side effects persist or cause concern, consulting a physician is advised to explore potential solutions or alternative treatments.
Certain patient populations should avoid taking Emvose M 0.3 Tablet, which includes individuals with type 1 diabetes mellitus, diabetic ketoacidosis (characterized by elevated blood acid levels), or severe kidney or liver conditions. Before initiating this medication, patients with a history of heart disease should disclose this information to their healthcare provider to assess suitability. Pregnant or breastfeeding women must seek medical advice before commencing treatment. Regular monitoring of blood sugar levels is imperative, and physicians may recommend periodic blood tests to evaluate blood cell counts and liver functionality for optimal management of diabetes.
Disclaimer
The information provided on this website is to the best of our abilities to ensure it is accurate, reliable, and reviewed by a team of professionals. It should not be used to diagnose, prevent, or cure any health problem. The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment. The absence or provision of any information or warning regarding any medicine should not be assumed as an implied or explicit assurance of safety or efficacy. We highly recommend consulting your registered medical practitioner for all queries or doubts related to your medical condition. Do not ignore professional medical advice or delay seeking it based on the content encountered on our website. We intend to support, not replace, the doctor-patient relationship.
₹54.45
₹60.5
10% OFF
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024
